Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 14Active not recruiting 6Terminated 4Recruiting 4Unknown 2Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 4

Conditions

Melanoma 29Carcinoma, Renal Cell 18Carcinoma, Non-Small-Cell Lung 13Carcinoma, Hepatocellular 10Brain Neoplasms 7Skin Neoplasms 6Neoplasm Metastasis 6Neoplasms 5Kidney Neoplasms 5Colorectal Neoplasms 5Clear-cell metastatic renal cell carcinoma 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Lung Neoplasms 4Carcinoma, Transitional Cell 4Triple Negative Breast Neoplasms 3Multiple Myeloma 3Mesothelioma 3Liver Neoplasms 3Breast Neoplasms 3Uveal Melanoma 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma 2Recurrence 2Prostatic Neoplasms 2Mycosis Fungoides 2Mesothelioma, Malignant 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2

Interventions

pembrolizumab 49Carboplatin 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Pemetrexed 35Cisplatin 26Blood Specimen Collection 25durvalumab 17Paclitaxel 17osimertinib 15Radiosurgery 15Bevacizumab 15Radiotherapy 14Nivolumab 14Gemcitabine 14atezolizumab 13Biopsy 13Drug Therapy 12Docetaxel 11130-nm albumin-bound paclitaxel 11Immunoglobulin G 10X-Rays 9Taxes 9Standard of Care 9Practice Guidelines as Topic 9Educational Status 9Disulfides 9tislelizumab 8Etoposide 8Cetuximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Lung Neoplasms × Ipilimumab × Clear all
NCT07394062 2026-05-18

ALCG-01

Gazi University

Recruiting
400 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06926790 2025-04-22

GALAXY 3

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting
69 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05501665 2024-10-17

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

Vanderbilt-Ingram Cancer Center

Phase 1/2 Recruiting
25 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06492421 2024-07-09

Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.

Second Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting
90 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡